Table 1. Splenic immune cell subset changes in non-tumor bearing BALB/c mice after administration of MVA-TWIST/TRICOM.
CD4+ T cells | CD8+ T cells | Effector Memory CD8+ T cells | Twist Tetramer+ CD8+ T cells | Dendritic cells | Activated Dendritic cells | |
---|---|---|---|---|---|---|
No Treatment | 26.10 (1.017) | 10.92 (0.2853) | 0.7470 (0.0473) | 2.43 | 1.390 (0.1243) | 0.2592 (0.0762) |
MVA-TWIST/TRICOM | 26.78 (0.5093) | 12.22 (0.2131) | 1.56 (0.1597)* | 3.83* | 1.410 (0.07629) | 0.5564 (0.0702)* |
Flow cytometric analysis of splenic immune cell subsets in BALB/c mice (n = 5/group). Animals were administered two weekly vaccinations with MVA-TWIST/TRICOM or left untreated. Spleens were harvested 17 days after the last vaccination. Data represented as “mean (SEM)” percentage of viable splenocytes. CD4+ T cells (CD3+ CD4+), CD8+ T cells (CD3+ CD8+), Effector Memory cells (CD3+CD8+CD44+CD62L-), Dendritic cells (CD11c+MHCII+) and Activated Dendritic cells (CD11c+MHCII+CD40+).
= p < 0.01 as determined by Student’s t test or the Kolmogorov-Smirnov test.